| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/15/2006 | EP1634874A1 Imidazolidine derivative |
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/15/2006 | EP1227085B1 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 03/15/2006 | EP1196172B1 (S,S)-Reboxetine for treating chronic pain |
| 03/15/2006 | EP1129078B1 Indazole derivatives with 5-ht2 receptor activity |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | CN1746171A Heterocyclic hepyramine derivative, its preparation and use thereof |
| 03/15/2006 | CN1746170A Poly-substituted pyridino-[4,3d] pyramine with antibacterial and herbicide activity and its production thereof |
| 03/15/2006 | CN1746164A Protein antagonist with water channel |
| 03/15/2006 | CN1745831A Chinese medicine for treating prostatitis, impotence and premature ejaculation, its preparation |
| 03/15/2006 | CN1745814A Medicament for treating prostatauxe inflammation |
| 03/15/2006 | CN1745808A Chinese medicinal composition for treating chronic prostate and its preparation |
| 03/15/2006 | CN1745777A Chinese medicine enema for treating chronic nephrosis |
| 03/15/2006 | CN1745776A Chinese patent drug for treating chronic nephrosis |
| 03/15/2006 | CN1745752A Medicinal compound preparation for treating benign prostatic hyperplasia |
| 03/15/2006 | CN1245508C Human atrial natriuretic peptide gene, its strong mutant and its application in treating relative diseases |
| 03/15/2006 | CN1245496C Preparation method of chinese caterpillar fungus wine |
| 03/15/2006 | CN1245417C Prodrugs of dipeptidyl peptidase IV inhibitors |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/15/2006 | CN1245194C Oral liquor for curing senile prostatic hyperplasia |
| 03/15/2006 | CN1245189C Composition for strengthening body resistance and restoring and function, strengthening spleen and kidney, relieving mental stress and promoting blood circulation to remove blood stasis |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012145 Method |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012076 Quinazoline-4-sulfonamide derivatives |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7011855 Biochemically balanced peritoneal dialysis solutions |
| 03/14/2006 | US7011825 Erythropoietin solution preparation |
| 03/14/2006 | CA2395131C Canine health diet |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2357687C New pyridazine endothelin antagonists |
| 03/14/2006 | CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/09/2006 | WO2006025490A1 Molecular chaperone function regulator |
| 03/09/2006 | WO2006025057A1 Use of il-6 in vascular complications |
| 03/09/2006 | WO2006024492A2 Medical implant provided with inhibitors of atp synthesis |
| 03/09/2006 | WO2006024491A1 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024490A2 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024489A2 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052457 Use of ppar alpha agonists for the treatment of vascular and renal diseases |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052398 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 03/09/2006 | US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051344 Antibody and utilization of the same |
| 03/09/2006 | CA2579012A1 Use of il-6 in vascular complications |
| 03/09/2006 | CA2577928A1 Molecular chaperone function regulator |
| 03/09/2006 | CA2577613A1 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 03/09/2006 | CA2577301A1 Substituted biaryl piperazinyl-pyridine analogues |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632235A2 Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| 03/08/2006 | EP1632234A2 (S,S)-reboxetine for treating chronic fatigue syndrome |
| 03/08/2006 | EP1632229A1 Medicaments for the treatment of urinary tract disorders comprising anticholinergic agents |
| 03/08/2006 | EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1423407B1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1387839B1 Process for the production of quinazolines |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1353926B1 Mikanolide derivatives, their preparation and therapeutic uses |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1347753B1 Topical composition and method for treating urinary stress incontinence |
| 03/08/2006 | EP1328285B1 Oral preparation containing seaweed for reduction of plaque and calculus |
| 03/08/2006 | EP1294389B1 Therapeutical use of sophora flavescens or sophora subprostrata extracts |
| 03/08/2006 | EP1278770B1 Human wingless-like gene |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1267886B1 Vitamin d compounds for the treatment of chronic allograft nephropathy in kidney transplant patients |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP0948327B1 Antidiabetic agents |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1744891A Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of EDHF function |
| 03/08/2006 | CN1744889A Controlled release pharmaceutical compositions of tamsulosin |
| 03/08/2006 | CN1743312A Fused-polycyclic compounds |
| 03/08/2006 | CN1742989A Chinese herbal medicinal decoction for treating blood-stasis internal-depression type urinary stone and preparing method |
| 03/08/2006 | CN1742988A Chinese herbal decoction for treating liver-depressed Qi-stagnation type urinary stone and preparing method |
| 03/08/2006 | CN1742975A Paerpi pill |
| 03/08/2006 | CN1742963A Chinese medicine for treating diabets and nephritis |
| 03/08/2006 | CN1742954A Urotoxin clearing preparation-Niaoduqing |